Find trials
Search tips

Transcutaneous Delivery Using Syringe and Device-Assisted Methods in Ex-Vivo Human Skin

Overview

About this study

The purpose of this study is evaluate the efficacy of transcutaneous delivery of tattoo ink in ex-vivo human skin samples using different methods including needle-syringe method, oscillating needle device, and a microneedling device.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Skin samples from healthy patients undergoing surgery at Mayo Clinic Florida.

Exclusion Criteria:

  • Tissue samples from diseased skin.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 02/24/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Thais Pincelli, M.D.

Open for enrollment

Contact information:

Thais Pincelli M.D.

(904) 953-6402

Pincelli.Thais@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20584496

Mayo Clinic Footer